WV Allowed Product Forms — Pills, Oils, Vapes, Dry Leaf for Vaporization

Last verified: May 2026

Permitted Forms by Statute

Under W. Va. Code §§ 16A-3-3 and 16A-4-3, the following medical cannabis product forms may be sold at West Virginia dispensaries:

• Pills — capsules and tablets containing measured cannabinoid doses; popular with patients seeking precise dosing
• Oils — cannabis oil concentrates intended for ingestion or sublingual absorption (distinct from "vape oils")
• Topicals — gels, creams, ointments applied to skin; popular for localized pain management
• A form medically appropriate for vaporization or nebulization — vape cartridges, distillate, concentrate-loaded products
• Dry leaf or plant form for vaporization only — added by SB 339 (2020) after MCAB 2018 recommendation; this is what patients commonly call "flower"
• Tinctures — alcohol-, glycerin-, or oil-based liquid extracts taken sublingually
• Liquids — non-edible cannabinoid liquid products
• Transdermal patches — skin-applied controlled-release patches

The Critical "For Vaporization Only" Distinction

SB 386 (2017) originally banned dry leaf or plant form entirely — meaning vaporizable flower was illegal at WV dispensaries. The Medical Cannabis Advisory Board (MCAB) recommended whole-plant access in 2018, citing patient demand and the practical impossibility of enforcing a flower ban without crippling the program. The Legislature responded with SB 339 (2020), which added "dry leaf or plant form for vaporization only" to the permitted list.

The phrase "for vaporization only" matters. The statute does not authorize combustion (smoking). Patients can technically purchase dry leaf only for use in a vaporizer device. In practice, this distinction is unenforceable at the consumer level — a patient who buys dry leaf and ignites it in a pipe at home is committing a regulatory violation but not a separately prosecuted crime. For dispensary marketing, packaging, and OMC compliance, however, the language matters: dispensaries must label and market dry leaf as vaporization product, not "smokable flower." See no-flower / no-edibles / no-home-grow page.

Sales Mix — Patients Have Chosen Vaporization

Per OMC public reporting via The Transparency Project, the West Virginia medical cannabis sales mix breaks down as follows:

• Dry leaf (vape flower) ~65% of sales — the dominant category since SB 339 took effect
• Vape cartridges and concentrates ~30% of sales — with vape cartridges representing >60% of that subcategory (~18% of total)
• Pills, tinctures, topicals together <5% of sales

The 65% dry-leaf dominance is striking given that SB 386 originally banned the form entirely. It demonstrates that West Virginia patients, like patients in every other medical-cannabis state, prefer vaporized whole-plant material to standardized pharmaceuticals. The implication for the no-edibles ban is direct: if HB 5260 (2026) had passed the Senate, edibles would likely have captured 5-15% of the WV market within a year, comparable to early Pennsylvania edible adoption.

Common Product Subcategories at WV Dispensaries

Vape cartridges (510-thread)

Pre-filled cartridges containing distillate or live-resin oil. Compatible with standard 510-thread batteries. Brands at WV dispensaries include Trulieve in-house lines, Verano (Encore, Avexia, Verano Reserve), Holistic (Liberty, Strane), Curaleaf (Select, Grassroots), and Cannabist house brands. Strain-specific cartridges, terpene-tuned formulas, and 1:1 CBD:THC blends are widely available.

Disposable vapes

All-in-one disposable vape pens with built-in batteries. Convenient for new patients; less cost-efficient long term than cartridge + reusable battery.

Dry leaf (vape flower)

Sold in 1g, 3.5g (eighth), 7g (quarter), 14g (half-ounce), and occasionally 28g (full ounce) pre-packaged jars or pouches. Strain genetics include classics (OG Kush, Sour Diesel, GG#4, GSC, Wedding Cake) and modern hybrids. Pre-rolls (rolled joints) are available though "for vaporization" labeling sometimes feels strained on a pre-roll product.

Concentrates

Live resin, live rosin, distillate, RSO (Rick Simpson Oil), wax, badder, sugar. Concentrates require dab rigs, vaporizers, or cartridge filling. Concentrates fall under Hubbard v. Spillers (W.Va. 1974) for non-cardholders — see concentrates page — but for cardholders are simply another permitted form.

Tinctures & oils

Alcohol- or oil-based liquid extracts; sublingual administration; common formulations include 1:1 CBD:THC, high-CBD, and full-spectrum. Popular with older patients and those who prefer not to inhale.

Pills & capsules

Measured-dose capsules containing distillate or full-spectrum extract; common doses 5mg, 10mg, 20mg THC. Popular with patients who want pharmaceutical-style dosing precision and slow ingestion onset.

Topicals

Skin-applied creams, gels, ointments, salves; non-psychoactive when used as directed; popular for localized pain, arthritis, neuropathy. The fastest-growing topical category at WV dispensaries.

Transdermal patches

Controlled-release skin patches; less common but gaining patient interest for sustained-release dosing.

Testing & Labeling Requirements

All West Virginia medical cannabis products must pass independent laboratory testing for potency (cannabinoid content), residual solvents, pesticides, microbials, heavy metals, and mycotoxins under OMC rules promulgated under W. Va. Code Ch. 16A. Each package must display:

• OMC product registration number
• Cannabinoid content (mg/serving and mg/package, plus % when appropriate)
• Cultivator and processor identifiers
• Batch number and harvest date
• "Medical Cannabis — Not for Resale" warning
• METRC track-and-trace identifier (visible to dispensary point-of-sale)

What Is NOT Permitted

The forms expressly prohibited at WV dispensaries (see prohibited-forms page):

• Edibles — gummies, chocolates, baked goods, beverages, candies (HB 5260 (2026) would have allowed lozenges + gelatin in non-candy shapes, capped 10 mg THC/serving; passed House March 3, 2026; died in Senate before March 14 sine die)
• Smokable flower — combustion not authorized (dry leaf is "for vaporization only")
• Home-cultivation product — HB 5259 (2026) would have allowed 10 plants / 5 mature; failed